Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PLCG2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DCP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ENDOD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IDH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BMT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RHOBTB3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TUBB2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
MICAL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CNTN5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHLDA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTPRG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYO6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SP100 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRDM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHKA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNTTIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYO5B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRC61 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
XPOT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GNPTAB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on